3Murakawa M,Okamura T,Shibuya T,et al.Use of a synthetic protease inhibitor for the treatment of L-asparaginase-induced acute pancreatitis complicated by disseminated intravascular coagulation[J].Ann Hematol,1992,64(5):249.
4Halton JM,Mitchell LG,Vegh P,et al.Fresh frozen plasma has no beneficial effect on the homeostatic system in children receiving L-asparaginase[J].Am J Hematol,1994,47(3):157-161.
5Shapiro AD,Clarke SL,Christian JM,et al.Thrombosis in children receiving L-asparaginase[J].Am J Pediatr Oncol,1993,15(4):400.
6[3]MITCHELL LG,ANDREW M,HANNNA K,etal.Determining the prevalence of thrombotic events in children with acute lymphoblast leukemia and a central venous line who are treated with L 2asparagnase:results of the prophylactic antithrombin replacement in kid with acute lymphoblastic leukemia treated with asparagina (PARKAA) study[J].Cancer,2003,97(2):508-516.
7Sahu S，Pediat Hematol Oncol，1998年，15卷，6期，533页
8Lim H L，Singapore Med J，1998年，39卷，2期，76页
9郑文，中华医学杂志，1998年，78卷，1期，77页
10Mitchell LG,Andrew M,Hannna K,et al.Determining the prevalence of thrombotic events in children with acute lymphoblastic leudemia and a central venous line who are treated with L-asparaginase:results of the prophylactic antithrombin replacement in kids with acute lymphoblastic leukemia treated with asparaginase(PARKAA) study[J].Cancer,2003,15,97(2):508-516.
